Uterine fibroids are among the most common benign conditions affecting women of reproductive age. Research suggests that up to 70 to 80 percent of women will develop fibroids at some point in their lifetime, though the majority will never experience symptoms significant enough to require treatment. For women pursuing IVF, however, the presence of fibroids raises important questions that deserve careful clinical consideration before treatment begins.

Do fibroids affect IVF outcomes? Should they be treated before starting a cycle? If so, which ones and how? These are questions that do not have simple universal answers because the impact of fibroids on fertility depends heavily on their size, number, location within the uterus, and individual patient factors. Understanding the nuances of this relationship is essential for any woman with known fibroids who is preparing for IVF.

What Fibroids Are and How They Form

Uterine fibroids, also known as leiomyomas or myomas, are benign tumours of smooth muscle that grow within or around the walls of the uterus. They are not cancerous and have no potential to become cancerous. Their growth is driven primarily by estrogen and progesterone, which is why they tend to develop during the reproductive years, often grow during pregnancy when hormone levels are elevated, and typically shrink after menopause when estrogen production declines.

Fibroids vary enormously in size, ranging from microscopic lesions invisible to the naked eye to large masses that can distort the entire uterine architecture. They can be solitary or multiple, and their clinical significance depends almost entirely on their location rather than their size alone.

The three primary locations in which fibroids develop correspond to the three layers of the uterine wall. Submucosal fibroids grow into the uterine cavity itself, protruding from the inner lining of the uterus. Intramural fibroids develop within the muscular wall of the uterus without entering the cavity. Subserosal fibroids grow outward from the outer surface of the uterus into the pelvic cavity. A fourth type, pedunculated fibroids, are attached to the uterus by a stalk and can be either submucosal or subserosal in location.

How Fibroids Affect Fertility and IVF Outcomes

The relationship between fibroids and fertility is one of the most studied and most debated topics in reproductive medicine. The evidence consistently shows that the impact of fibroids on IVF outcomes is strongly location-dependent.

Submucosal fibroids have the clearest and most significant negative effect on IVF outcomes. By projecting into the uterine cavity, they physically distort the endometrial surface and interfere with the implantation process in multiple ways. They alter the blood supply to the overlying endometrium, create mechanical barriers to embryo attachment, and trigger local inflammatory responses that impair endometrial receptivity. Studies comparing IVF outcomes in women with and without submucosal fibroids have consistently found lower implantation rates, lower clinical pregnancy rates, and higher miscarriage rates in women with cavity-distorting fibroids. The evidence supporting removal of submucosal fibroids before IVF is strong and widely accepted in reproductive medicine guidelines.

Intramural fibroids present a more nuanced picture. Small intramural fibroids that do not distort the uterine cavity have limited evidence of impact on IVF outcomes, and most specialists do not recommend treating them before a first IVF attempt. However, larger intramural fibroids, typically those exceeding four centimetres in diameter, have been associated with reduced implantation and pregnancy rates in some studies, likely because of their effect on uterine contractility, blood flow to the endometrium, and the mechanical environment of the uterine cavity even without direct cavity distortion. The decision about whether to treat larger intramural fibroids before IVF requires individualised clinical judgement and should be made in consultation with a specialist experienced in fibroid management and fertility treatment.

Subserosal fibroids, which grow outward from the uterine surface and do not impinge on the cavity, have the least evidence of impact on IVF outcomes. Most evidence suggests that subserosal fibroids do not significantly affect implantation rates or pregnancy outcomes, and surgical treatment before IVF is not routinely recommended for this fibroid type.

Diagnosing Fibroids Before IVF

Accurate characterisation of fibroids before IVF is essential for appropriate management decisions. The diagnostic tools most commonly used include transvaginal ultrasound, sonohysterography, hysteroscopy, and MRI.

Transvaginal ultrasound is the standard first-line investigation and provides good visualisation of fibroid size, number, and general location. However, it can miss small submucosal fibroids and may not clearly delineate the relationship between intramural fibroids and the uterine cavity.

Sonohysterography, in which sterile saline is instilled into the uterine cavity during ultrasound, provides significantly better visualisation of the cavity and can clearly identify submucosal fibroids and intramural fibroids with cavity involvement that standard ultrasound may underestimate.

Hysteroscopy provides direct visual inspection of the uterine cavity and is both diagnostic and potentially therapeutic, as small submucosal fibroids can often be removed hysteroscopically at the same time as the diagnostic procedure.

MRI is the most accurate imaging modality for fibroid characterisation, particularly in women with multiple fibroids or where the relationship between fibroids and the uterine cavity is unclear on ultrasound. It provides detailed information about fibroid size, location, vascularity, and the integrity of the remaining uterine wall that is particularly valuable in surgical planning.

Surgical Options for Fibroids Before IVF

When fibroid treatment before IVF is indicated, the surgical approach depends on fibroid type, size, number, and location.

Hysteroscopic myomectomy is the preferred approach for submucosal fibroids. It is performed through the cervix without any external incisions, involves a short recovery period of typically one to two weeks, and is associated with excellent restoration of the uterine cavity in experienced hands. Most women can proceed to IVF two to three months after hysteroscopic myomectomy, allowing adequate time for endometrial healing.

Laparoscopic or open myomectomy is used for intramural and subserosal fibroids that require treatment. The approach depends on fibroid size, number, and the surgeon's expertise. Laparoscopic myomectomy offers the advantages of minimally invasive surgery including shorter recovery time and reduced adhesion formation. Open myomectomy may be necessary for very large or numerous fibroids that cannot be safely removed laparoscopically.

Following myomectomy, a recovery period before IVF is typically recommended to allow complete uterine healing. The duration varies depending on the extent of surgery and the depth of uterine wall involvement. Your specialist will advise on the appropriate interval between surgery and IVF based on your individual procedure and recovery.

An important consideration in fibroid surgery before IVF is the risk of adhesion formation following myomectomy, particularly after open procedures. Intrauterine adhesions can develop following hysteroscopic myomectomy if the procedure involves extensive resection or if fibroids on opposing walls are treated simultaneously. Post-operative hysteroscopy three to four months after surgery can confirm complete healing and cavity restoration before IVF proceeds.

When to Proceed Directly to IVF Without Fibroid Treatment

Not every woman with fibroids needs surgery before IVF. The decision to treat or not treat should be based on a careful weighing of the likely impact of the fibroid on IVF outcomes against the risks of surgical intervention and the delay it introduces to treatment.

For women with small intramural fibroids not distorting the cavity, subserosal fibroids, or multiple small fibroids where surgery would be extensive and the evidence of benefit limited, proceeding directly to IVF is often the most appropriate recommendation. If the first cycle is unsuccessful despite good embryo quality, fibroid treatment may then be reconsidered as part of the post-cycle review.

For women with diminished ovarian reserve where time is a particularly precious resource, the balance between waiting for fibroid surgery and recovery versus proceeding with IVF while fibroids are present requires especially careful individualised consideration.

Connecting with an experienced fertility hospital in jaipur that takes a thorough, evidence-based approach to fibroid assessment before IVF ensures that the decision to treat or not treat your fibroids is made on the basis of accurate imaging, clinical expertise, and your individual reproductive profile rather than a one-size-fits-all recommendation.

Fibroids During IVF and Pregnancy

Women who proceed with IVF in the presence of untreated fibroids require monitoring throughout the cycle and subsequent pregnancy. During ovarian stimulation, rising estrogen levels can cause fibroids to enlarge, though this is usually temporary and reverses after the cycle.

During pregnancy following IVF, fibroids may grow in response to the elevated hormonal environment of early pregnancy and can in some cases cause complications including pain from fibroid degeneration, placental abruption if the placenta implants adjacent to a fibroid, preterm labour, and malpresentation at delivery. Close obstetric monitoring throughout the pregnancy is essential for women with significant fibroids.

For personalised guidance on fibroid management within your IVF journey, a trusted test tube baby center in jaipur with experienced reproductive specialists and access to comprehensive diagnostic and surgical services provides the integrated care that women with fibroids pursuing IVF genuinely need.

Final Thoughts

Fibroids are common, but their impact on IVF outcomes is neither universal nor inevitable. The key is accurate diagnosis, careful classification by location and size, and individualised clinical decision-making about whether treatment before IVF is genuinely indicated in your specific case.

Not every fibroid needs to be treated. Not every fibroid can be safely ignored. Understanding the difference, with the guidance of an experienced specialist, is the foundation of a well-planned IVF journey for any woman with this condition.